AAAAAA
Results:
1-23
|
Results: 23
Authors:
Tilg, H
Citation: H. Tilg, Non-alcoholic steatohepatitis - Reply, DEUT MED WO, 126(33), 2001, pp. 930-930
Authors:
Tilg, H
Citation: H. Tilg, Nonalcoholic steatohepatitis: epidemiology, diagnosis and treatment, DEUT MED WO, 126(16), 2001, pp. 467-471
Authors:
Tilg, H
Citation: H. Tilg, Cytokines and liver diseases, CAN J GASTR, 15(10), 2001, pp. 661-668
Authors:
Kaser, A
Tilg, H
Citation: A. Kaser et H. Tilg, Interferon-alpha in inflammation and immunity, CELL MOL B, 47(4), 2001, pp. 609-617
Authors:
Molnar, C
Lechleitner, M
Wetscher, G
Tilg, H
Citation: C. Molnar et al., A woman with vomiting and depression, LANCET, 358(9288), 2001, pp. 1154-1154
Authors:
Stoitzner, P
Ratzinger, G
Koch, F
Janke, K
Scholler, T
Kaser, A
Tilg, H
Cruikshank, WW
Fritsch, P
Romani, N
Citation: P. Stoitzner et al., Interleukin-16 supports the migration of Langerhans cells, partly in a CDL4-independent way, J INVES DER, 116(5), 2001, pp. 641-649
Authors:
Reich, K
Heine, A
Hugo, S
Blaschke, V
Middel, P
Kaser, A
Tilg, H
Blaschke, S
Gutgesell, C
Neumann, C
Citation: K. Reich et al., Engagement of the Fc epsilon RI stimulates the production of IL-16 in Langerhans cell-like dendritic cells, J IMMUNOL, 167(11), 2001, pp. 6321-6329
Authors:
Dunzendorfer, S
Kaser, A
Meierhofer, C
Tilg, H
Wiedermann, CJ
Citation: S. Dunzendorfer et al., Cutting edge: Peripheral neuropeptides attract immature and arrest mature blood-derived dendritic cells, J IMMUNOL, 166(4), 2001, pp. 2167-2172
Authors:
Kaser, A
Brandacher, G
Steurer, W
Kaser, S
Offner, FA
Zoller, H
Theurl, I
Widder, W
Molnar, C
Ludwiczek, O
Atkins, MB
Mier, JW
Tilg, H
Citation: A. Kaser et al., Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis, BLOOD, 98(9), 2001, pp. 2720-2725
Authors:
Molnar, C
Buratti, T
Wiedermann, CJ
Tilg, H
Citation: C. Molnar et al., Hepatocyte growth factor plasma levels after myocardial infarction are notaffected by recombinant tissue-type plasminogen-activator therapy, EUR CYTOKIN, 11(1), 2000, pp. 87-90
Authors:
Dejaco, C
Reinisch, W
Lichtenberger, C
Waldhoer, T
Kuhn, I
Tilg, H
Gasche, C
Citation: C. Dejaco et al., In vivo effects of recombinant human interleukin-10 lymphocyte phenotypes and leukocyte activation markers inflammatory bowel disease, J INVES MED, 48(6), 2000, pp. 449-456
Authors:
Dunzendorfer, S
Kaser, A
Meierhofer, C
Tilg, H
Wiedermann, CJ
Citation: S. Dunzendorfer et al., Dendritic cell migration in different micropore filter assays, IMMUNOL LET, 71(1), 2000, pp. 5-11
Authors:
Tilg, H
Diehl, AM
Citation: H. Tilg et Am. Diehl, Mechanisms of disease: Cytokines in alcoholic and nonalcoholic steatohepatitis., N ENG J MED, 343(20), 2000, pp. 1467-1476
Authors:
Kaser, A
Dunzendorfer, S
Offner, FA
Ludwiczek, O
Enrich, B
Koch, RO
Cruikshank, WW
Wiedermann, CJ
Tilg, H
Citation: A. Kaser et al., B lymphocyte-derived IL-16 attracts dendritic cells and Th cells, J IMMUNOL, 165(5), 2000, pp. 2474-2480
Authors:
Tilg, H
Kaser, A
Citation: H. Tilg et A. Kaser, Interferons and their role in inflammation, CUR PHARM D, 5(10), 1999, pp. 771-785
Authors:
Vannier, E
Kaser, A
Atkins, MB
Fantuzzi, G
Dinarello, CA
Mier, JW
Tilg, H
Citation: E. Vannier et al., Elevated circulating levels of soluble interleukin-1 receptor type II during interleukin-2 immunotherapy, EUR CYTOKIN, 10(1), 1999, pp. 37-41
Authors:
Kaser, A
Nagata, S
Tilg, H
Citation: A. Kaser et al., Interferon alpha augments activation-induced T cell death by upregulation of Fas (CD95/APO-1) and Fas ligand expression, CYTOKINE, 11(10), 1999, pp. 736-743
Authors:
Kaser, A
Vogel, W
Tilg, H
Citation: A. Kaser et al., Plasma levels of soluble Fas during treatment of chronic hepatitis C patients with interferon alpha, J HEPATOL, 31(3), 1999, pp. 575-575
Authors:
Schratzberger, P
Dunzendorfer, S
Reinisch, N
Buratti, T
Kahler, CM
Tilg, H
Herold, M
Wiedermann, CJ
Citation: P. Schratzberger et al., Mediator-dependent effects of pentoxifylline on endothelium for transmigration of neutrophils, IMMUNOPHARM, 41(1), 1999, pp. 65-75
Authors:
Kaser, A
Deisenhammer, F
Berger, T
Tilg, H
Citation: A. Kaser et al., Interferon-beta(1b) augments activation-induced T-cell death in multiple sclerosis patients, LANCET, 353(9162), 1999, pp. 1413-1414
Authors:
Lochs, H
Adler, G
Beglinger, C
Duchmann, R
Emmrich, J
Ewe, K
Gangl, A
Gasche, C
Hahn, E
Hoffmann, P
Kaskas, B
Malchow, H
Pohl, C
Raedler, A
Renner, E
Scholmerich, J
Schreiber, S
Stange, E
Tilg, H
Vogelsang, H
Weigert, N
Zeitz, M
Citation: H. Lochs et al., Anti-TNF antibody in Crohn's disease - status of information, comments andrecommendations of an international working group, Z GASTROENT, 37(6), 1999, pp. 509-512
Authors:
Kaser, A
Dunzendorfer, S
Offner, FA
Ryan, T
Schwabegger, A
Cruikshank, WW
Wiedermann, CJ
Tilg, H
Citation: A. Kaser et al., A role for IL-16 in the cross-talk between dendritic cells and T cells, J IMMUNOL, 163(6), 1999, pp. 3232-3238
Authors:
Kaser, A
Enrich, B
Ludwiczek, O
Vogel, W
Tilg, H
Citation: A. Kaser et al., Interferon-alpha (IFN-alpha) enhances cytotoxicity in healthy volunteers and chronic hepatitis C infection mainly by the perforin pathway, CLIN EXP IM, 118(1), 1999, pp. 71-77
Risultati:
1-23
|